PSEUDOVITELLIFORM MACULOPATHY SECONDARY TO BRAF AND MEK INHIBITORS IN A PATIENT WITH METASTASIC MELANOMA

被引：0
|
作者：
Alba-Linero, C. [1 ]
Rocha De Lossada, C. [1 ]
Delgado-Fernandez, A. S. [1 ]
Jodar-Marquez, M. [1 ]
Calvo De Mora, M. Rodriguez [1 ]
Berciano-Guerrero, M. A. [2 ]
机构：
[1] Hosp Reg Malaga, Plaza Hosp Civil, Ophthalmol Dept, Malaga 29009, Spain
[2] Hosp Reg Malaga, Oncol Dept, Malaga, Spain
来源：
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2019年 / 33卷 / 05期
关键词：
neuroepithelial detachment; metastasic melanoma; BRAF inhibitors; MEK inhibitors; pseudovitelliform;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1497 / 1500
页数：4
相关论文
共 50 条
  • [41] Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
    Carlino, Matteo S.
    Todd, Jason R.
    Gowrishankar, Kavitha
    Mijatov, Branka
    Pupo, Gulietta M.
    Fung, Carina
    Snoyman, Stephanie
    Hersey, Peter
    Long, Georgina V.
    Kefford, Richard F.
    Rizos, Helen
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 544 - 554
  • [42] Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma
    Sada, Ikuyo
    Harada, Yosuke
    Hiyama, Tomona
    Mizukami, Mina
    Kan, Takanobu
    Kawai, Mikio
    Kiuchi, Yoshiaki
    MELANOMA RESEARCH, 2023, 33 (06) : 539 - 546
  • [43] Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors forMetastatic Melanoma
    Carlos, Giuliana
    Anforth, Rachael
    Clements, Arthur
    Menzies, Alexander M.
    Carlino, Matteo S.
    Chou, Shaun
    Fernandez-Penas, Pablo
    JAMA DERMATOLOGY, 2015, 151 (10) : 1103 - 1109
  • [44] Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma
    F. Consoli
    M. Bersanelli
    G. Perego
    S. Grisanti
    B. Merelli
    A. Berruti
    F. Petrelli
    Clinical and Translational Oncology, 2020, 22 : 900 - 907
  • [45] Use of proton pump inhibitors in people taking BRAF/MEK inhibitors for metastatic melanoma
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (04) : E29 - E29
  • [46] Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors
    Bormann, Jordan L.
    Kerkvliet, Amy M.
    CUTIS, 2023, 112 (03): : E17 - E20
  • [47] Recurrent tattoo reactions in a patient treated with BRAF and MEK inhibitors
    Reinhard, R.
    Gebhardt, C.
    Schmieder, A.
    Umansky, V.
    Utikal, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (08) : E375 - E377
  • [48] TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro
    Delyon, Julie
    Vallet, Anais
    Bernard-Cacciarella, Melanie
    Kuzniak, Isabelle
    Reger de Moura, Coralie
    Louveau, Baptiste
    Jouenne, Fanelie
    Mourah, Samia
    Lebbe, Celeste
    Dumaz, Nicolas
    CANCERS, 2023, 15 (11)
  • [49] Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma
    Consoli, F.
    Bersanelli, M.
    Perego, G.
    Grisanti, S.
    Merelli, B.
    Berruti, A.
    Petrelli, F.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (06): : 900 - 907
  • [50] Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors
    Bonnefin, Charlotte
    Duval, Fanny
    Rouanet, Marie
    Kostine, Marie
    Gerard, Emilie
    FRONTIERS IN ONCOLOGY, 2023, 13
12345